Investing
The Israeli startup raised the first $50 million in April 2020 in a round led by Insight Partners, which led this extension as well.
This brings the company's total valuation to $1.7 billion.
The company is initially targeting the large employer market with its app-connected biometric monitoring tools.
The company currently manages one million lives, and plans to expand its footprint with the new funds.
The investment from "a leading national Integrated Delivery Network" brings the Series D's total to $100 million.
Set to close in Q2, the deal will provide the payer's healthcare services subsidiary with an integrated virtual care offering.
The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
Also: Medisafe lands $30 million in a round led by Sanofi and January AI rakes in $8.8 million for glycemic response tool.
Newly unveiled Circulo shares investors and a CEO with the healthcare automation unicorn.
New investor GV led the round, with participation from existing investors Jerusalem Venture Partners, Upfront Ventures, RRE Ventures and Rho Capital Partners.